American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Berger
    Berger
  7. Baselga
    Baselga
  8. Reis-Filho
    Reis-Filho
  9. Cordon-Cardo
    Cordon-Cardo
  10. Schultz
    Schultz

Groups

  1. Department of Medicine (2074)
  2. Solid Tumor Oncology Division (1737)
  3. GSK Faculty (1623)
  4. Sloan Kettering Institute Faculty (794)
  5. Sloan Kettering Institute Postdocs (766)
  6. Department of Pathology and Laboratory Medicine (715)
  7. Human Oncology and Pathogenesis Program (677)
  8. Surgery (639)
  9. Breast Medicine Service (605)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (570)
Search Within
Formats
  1. Meeting Abstract (1996)
  2. Journal Article (1966)
  3. Editorial (41)
  4. Review (22)
  5. Conference Paper (14)
  6. Correspondence (4)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2074)
  2. Solid Tumor Oncology Division (1737)
  3. GSK Faculty (1623)
  4. Sloan Kettering Institute Faculty (794)
  5. Sloan Kettering Institute Postdocs (766)
  6. Department of Pathology and Laboratory Medicine (715)

More Groups

People
  1. David Solit (174)
  2. Marc Ladanyi (157)
  3. Neal Rosen (141)
  4. Clifford Hudis (140)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (6)
  2. 2024 (55)
  3. 2023 (63)
  4. 2022 (261)
  5. 2021 (233)
  6. 2020 (271)

More Years

Publications
  1. Cancer Research (2685)
  2. Clinical Cancer Research (1363)

Results (4048)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cholesterol metabolism gene expression and prostate cancer-specific outcomes in radiotherapy-treated patients
    Meeting Abstract

    Winter, S. J.; Halliday, S.; Stopsack, K. H.; Osman, S. O.; Hounsell, A. R.; Prue, G.; Jain, S.; Allott, E. H.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Molecular characteristics of repotrectinib that enable potent inhibition of TRK fusion proteins and broad mutant selectivity
    Meeting Abstract

    Drilon, A.; Zhai, D.; Rogers, E.; Deng, W.; Chen, X.; Sprengeler, P.; Reich, S. H.; Murray, B. W.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Decoding the intimate dialogues between stem cells and immune cell for cancer immunotherapy
    Meeting Abstract

    Truong, C.; Guo, W.; Rudensky, A.; Fuchs, E.; Miao, Y. P.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Identification and characterization of the PIK3R1-mutant subtype in PI3K-addicted prostate cancer
    Meeting Abstract

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Rajanala, S. H.; Nguyen, B.; Ghale, R.; Mazzu, Y. Z.; Jehane, L. E.; Lee, G. S. M.; Mucci, L. A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • PRMT5 inhibition regulates alternative splicing and DNA damage repair pathways in SF3B1 R625G expressing uveal melanoma cells
    Meeting Abstract

    Ito, K.; Thodima, V.; Carter, J.; Bhagwat, N.; Sivakumar, M.; Grego, A.; Rager, J.; Terai, M.; Sato, T.; Abdel-Wahab, O.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Epigenetic mechanisms of endocrine therapy response in breast cancer
    Meeting Abstract

    Toska, E.; Xu, G.; Arruabarrena-Aristorena, A.; Scaltriti, M.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • ENVASARC: A pivotal trial of envafolimab, and envafolimab in combination with ipilimumab, in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy
    Meeting Abstract

    D'Angelo, S.; Robinson, S.; Lam, J.; Adams, B.; Freddo, J.; Theuer, C. P.; Maki, R.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • High quality neoantigens are immunoedited in long term survivors of pancreatic cancer
    Meeting Abstract

    Luksza, M.; Sethna, Z.; Rojas, L.; Soares, K.; Elhanati, Y.; Lihm, J.; Hoyos, D.; Kappagantula, R.; Moore, A. M.; Patterson, E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Integrated approach towards defining mechanism based combinations to guide clinical development of glutaminase inhibitors
    Meeting Abstract

    Kovacs, J. J.; Spencer, N. D.; Bristow, C. A.; Carugo, A.; Giluiani, V.; Miller, M. A.; Harris, A.; Feng, N.; Soth, M. L.; Le, K.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • MYC promotes tyrosine kinase inhibitor resistance in ROS1 fusion positive lung cancers
    Meeting Abstract

    Iyer, S. R.; Odintsov, I.; Schoenfeld, A. J.; Sato, H.; Siau, E.; Drilon, A.; Riely, G. J.; Somwar, R.; Ladanyi, M.; Davare, M. A.
    Cancer Research (2021)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: